| BGF WORLD HEALTHSCIENCE A2 JPY (HEDGED) | BIOTECNOLOGÍA | 6,776977 | 30/03/2026 | -6,90% | -23,60% | * |
| BGF WORLD HEALTHSCIENCE A2 EUR (HEDGED) | BIOTECNOLOGÍA | 14,400000 | 30/03/2026 | -7,10% | 5,80% | * |
| BGF WORLD HEALTHSCIENCE E2 EUR (HEDGED) | BIOTECNOLOGÍA | 10,440000 | 30/03/2026 | -7,20% | 4,30% | * |
| JANUS HENDERSON GLOBAL LIFE SCIENCES H2 EUR HEDGED | BIOTECNOLOGÍA | 29,840000 | 30/03/2026 | -7,21% | 23,61% | *** |
| JANUS HENDERSON GLOBAL LIFE SCIENCES I2 EUR HEDGED | BIOTECNOLOGÍA | 48,050000 | 30/03/2026 | -7,36% | 21,09% | *** |
| JANUS HENDERSON GLOBAL LIFE SCIENCES A2 EUR HEDGED | BIOTECNOLOGÍA | 46,810000 | 30/03/2026 | -7,54% | 18,15% | ** |
| L&G HEALTHCARE BREAKTHROUGH UCITS ETF | BIOTECNOLOGÍA | 11,588993 | 30/03/2026 | -8,25% | 4,77% | ** |
| A&P LIFESCIENCE FUND, FI A | BIOTECNOLOGÍA | 7,697613 | 30/03/2026 | -9,13% | 26,64% | *** |
| A&P LIFESCIENCE FUND, FI B | BIOTECNOLOGÍA | 7,421767 | 30/03/2026 | -9,31% | 23,46% | *** |
| FRANKLIN GENOMIC ADVANCEMENTS I (ACC) EUR | BIOTECNOLOGÍA | 6,280000 | 30/03/2026 | -11,17% | -0,79% | ** |
| FRANKLIN GENOMIC ADVANCEMENTS I (ACC) USD | BIOTECNOLOGÍA | 5,407524 | 30/03/2026 | -11,26% | -1,07% | ** |
| FRANKLIN GENOMIC ADVANCEMENTS W (ACC) USD | BIOTECNOLOGÍA | 5,390108 | 30/03/2026 | -11,30% | -1,38% | ** |
| FRANKLIN GENOMIC ADVANCEMENTS A (YDIS) EUR | BIOTECNOLOGÍA | 6,040000 | 30/03/2026 | -11,31% | -3,51% | ** |
| FRANKLIN GENOMIC ADVANCEMENTS A (ACC) USD | BIOTECNOLOGÍA | 5,181122 | 30/03/2026 | -11,51% | -3,92% | ** |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) EUR | BIOTECNOLOGÍA | 5,830000 | 30/03/2026 | -11,53% | -5,66% | ** |
| FRANKLIN GENOMIC ADVANCEMENTS C (ACC) USD | BIOTECNOLOGÍA | 5,050505 | 30/03/2026 | -11,56% | -5,53% | ** |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) USD | BIOTECNOLOGÍA | 5,015674 | 30/03/2026 | -11,64% | -6,02% | ** |
| CPR INVEST MEDTECH R ACC | BIOTECNOLOGÍA | 105,840000 | 27/03/2026 | -13,29% | -2,87% | * |
| CPR INVEST MEDTECH A ACC | BIOTECNOLOGÍA | 101,830000 | 27/03/2026 | -13,45% | -4,78% | * |
| ABANTE GLOBAL FUNDS - ABANTE LIFE SCIENCES FUND A EUR HEDGED CAP | BIOTECNOLOGÍA | 6,482000 | 09/04/2024 | · | · | ND |
